 |
Non-Nucleoside Reverse Transcriptase Inhibitors
HIV-Related Drug Classes Navigation |
||
| Anti-HIV Drug Classes (Home) | ||
delavirdine (Rescriptor ®) |
|
Dosing (Adult): 400mg orally
three times daily. Supplied: 100, 200mg tablets. Warn of rash. |
efavirenz (Sustiva ® ) |
|
Dosing (Adult): > 40kg: 600 mg
orally at bedtime. Supplied: [50,100,200mg capsule]. Warn of CNS toxicity that is usually self-limited to the first three weeks of treatment. May need to avoid driving or work during this period. |
nevirapine (Viramune ®) |
|
Dosing (Adult): Initially, 200mg
orally once a day for 14 days, then 200mg orally twice daily (may reduce
risk of rash). Supplied: [200mg tablet; 50mg/5 ml oral suspension]. Warn of hepatotoxicity with need to monitor liver function tests, especially during the first 12 weeks. |
Disclaimer
|
|
Listed dosages are for - Adult patients ONLY. PLEASE READ THE
DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
GlobalRPH does not directly or indirectly practice medicine or provide
medical services and therefore assumes no liability whatsoever of any
kind for the information and data accessed through the Service or for
any diagnosis or treatment made in reliance thereon. David F. McAuley, Pharm.D., R.Ph. GlobalRPh Inc. |
| Disclaimer Contact Us Privacy Policy Website Search | We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc. |
 |
 |